CLIC1支持与血小板激活和血栓形成相关的机制
Lynn M Knowles1, Emmanuel Ampofo2, Michael D Menger2
1Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University and University Medical Center, Homburg, Germany.
概括
化物细胞内通道1 (CLIC1) 通过与整合素相互作用,支持内皮细胞扩散和血小板聚合. 抑制CLIC1延迟了血栓形成,突出了其在血管健康中的作用.
科学领域:
- 细胞生物学 细胞生物学
- 血管生物学 血管生物学
- 生物化学 生化学
背景情况:
- 化物细胞内通道1 (CLIC1) 存在于内皮细胞和血小板中.
- 它在细胞粘附和功能中的确切作用仍在研究中.
研究的目的:
- 阐明CLIC1在内皮细胞和血小板中的作用机制.
- 研究CLIC1在整合素介导的细胞过程和血栓形成中的作用.
主要方法:
- 利用光显微镜,流细胞计和光传输聚合计来研究在培养细胞中的CLIC1.
- 采用小鼠背部皮肤折叠室模型来评估体内血栓形成.
主要成果:
- 通过CLIC1 knockdown 损害了内皮细胞的扩散,CLIC1局部化到lamellipodia,并通过整体素αvβ3.3与F-actin共局部化.
- 抑制CLIC1降低了F-actin的形成,并支持整合蛋白β3介导的细胞骨动力学.
- 在血小板中,CLIC1与Lamellipodia中的F-actin共定位,并以整体因子依赖的方式迁移到细胞表面.
- 抑制CLIC1减少了血小板聚合,整合素αIIbβ3激活,并延迟了体内血栓形成.
结论:
- 细胞膜中CLIC1的转移是由内皮细胞和血小板中的整合素-连接体相互作用调节的.
- 这种转移对整合素介导的功能至关重要,特别是体外和体内血小板血栓的形成.
相关概念视频
01:22Formation of the Platelet Plug
5.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.1K
01:18Structure and Function of Platelets
1.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
636
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
636
01:16Clot Retraction and Fibrinolysis
4.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.7K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
6.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.3K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
483
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
483